Stem Cell Mobilization and Harvesting Failure in Case of Heavily Pretreated Patients

1. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cell matter? Blood. 2001;98:2900-2908.Search in Google Scholar

2. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997; 89:2233-2258.10.1182/blood.V89.7.2233Search in Google Scholar

3. Jillella AP, Ustun C. What is the optimum number of CD34 peripheral blood stem cells for an autologous transplant? Stem Cells Dev. 2004;13:598-606.10.1089/scd.2004.13.59815684827Open DOISearch in Google Scholar

4. Vose JM, Ho AD, Coiffier B, et al. Advances in mobilization for the optimization of autologous stem cell transplantation. Leuk Lymphoma. 2009;50:1412-1421.10.1080/1042819090309670119603345Search in Google Scholar

5. Sancho JM, Morgades M, Grifols JR, et al. Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+ cell count to guide pre-emptive or immediate rescue mobilization. Cytotherapy. 2012;14:823-829.10.3109/14653249.2012.68104222540329Open DOISearch in Google Scholar

6. To LB, Levesque JP, Herbert KE. How I treat patients who mobilize hematopoietic stem cells poorly. Blood. 2011;118:4530-4540.10.1182/blood-2011-06-31822021832280Search in Google Scholar

7. Verfaillie CM. Hematopoietic stem cells for transplantation. Nature Immunology. 2002;3:314-317.10.1038/ni0402-31411919566Open DOISearch in Google Scholar

8. Pozotrigo M, Adel N, Landau L, et al. Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the area of novel therapies: experience at Memorial Sloan Kattering Cancer Center. Bone Marrow Transplantation. 2013;48:1033-1039.10.1038/bmt.2012.28123334269Search in Google Scholar

9. Worel N, Rosskopf K, Neumeister P, et al. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program. Transfusion. 2011;51:968-975.10.1111/j.1537-2995.2010.02896.x20880037Open DOISearch in Google Scholar

10. Nur Ozkurt Z, Yegin AZ, Suyan E, et al. Factors Affecting Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplantation. Journal of Clinical Apheresis. 2010;25:280-286.10.1002/jca.2024620623783Search in Google Scholar